Application | Comment | Organism |
---|---|---|
diagnostics | the urea cycle metabolite argininosuccinate is a common metabolic biomarker of FH deficiency | Mus musculus |
diagnostics | the urea cycle metabolite argininosuccinate is a common metabolic biomarker of FH deficiency | Homo sapiens |
medicine | loss of function of fumarate hydratase, the mitochondrial tumor suppressor and tricarboxylic acid cycle enzyme, is associated with a highly malignant form of papillary and collecting duct renal cell cancer The accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells from Fh1-deficient humans, making these cells auxotrophic for arginine, which opens a therapeutic perspective for the cure of hereditary leiomyomatosis and renal cell cancer | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
fumarate + L-arginine | Mus musculus | accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells | 2-(Nomega-L-arginino)succinate | - |
r | |
fumarate + L-arginine | Homo sapiens | accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells | 2-(Nomega-L-arginino)succinate | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
kidney | - |
Mus musculus | - |
kidney | - |
Homo sapiens | - |
kidney cancer cell | - |
Mus musculus | - |
kidney cancer cell | - |
Homo sapiens | - |
UOK-262 cell | fumarate hydratase defiecient or proficient cells, the latter termed UOKpFH cells | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-(Nomega-L-arginino)succinate | - |
Mus musculus | fumarate + L-arginine | - |
r | |
2-(Nomega-L-arginino)succinate | - |
Homo sapiens | fumarate + L-arginine | - |
r | |
fumarate + L-arginine | accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells | Mus musculus | 2-(Nomega-L-arginino)succinate | - |
r | |
fumarate + L-arginine | accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells | Homo sapiens | 2-(Nomega-L-arginino)succinate | - |
r |
Synonyms | Comment | Organism |
---|---|---|
ASL | - |
Mus musculus |
ASL | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | an increase in aspartate- and citrulline-derived argininosuccinate is a consequence of enzyme inhibition by high levels of fumarate in fumarate hydratase-deficient cells. In these cells, argininosuccinate is not produced from citrulline and aspartate in FH-deficient cells but rather from arginine and fumarate | Mus musculus |
malfunction | argininosuccinate aciduria is observed in patients deficient in the enzyme. An increase in aspartate- and citrulline-derived argininosuccinate is a consequence of enzyme inhibition by high levels of fumarate in fumarate hydratase-deficient cells. In these cells, argininosuccinate is not produced from citrulline and aspartate in FH-deficient cells but rather from arginine and fumarate | Homo sapiens |
additional information | depleting arginine from the growth media by the addition of pegylated arginine deiminase decreases the production of argininosuccinate in FH-deficient cells and reduces cell survival and proliferation | Mus musculus |
additional information | depleting arginine from the growth media by the addition of pegylated arginine deiminase decreases the production of argininosuccinate in FH-deficient cells and reduces cell survival and proliferation | Homo sapiens |
physiological function | loss of function of fumarate hydratase, the mitochondrial tumor suppressor and tricarboxylic acid cycle enzyme, is associated with a highly malignant form of papillary and collecting duct renal cell cancer. The accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells from Fh1-deficient humans, making these cells auxotrophic for arginine, which opens a therapeutic perspective for the cure of hereditary leiomyomatosis and renal cell cancer. The urea cycle metabolite argininosuccinate is a common metabolic biomarker of FH deficiency | Homo sapiens |
physiological function | loss of function of fumarate hydratase, the mitochondrial tumor suppressor and tricarboxylic acid cycle enzyme, is associated with a highly malignant form of papillary and collecting duct renal cell cancer. The accumulation of fumarate leads to reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells from Fh1-deficient mice, making these cells auxotrophic for arginine | Mus musculus |